8.78
price down icon0.23%   -0.02
after-market Handel nachbörslich: 8.72 -0.06 -0.68%
loading

Sage Therapeutics Inc Aktie (SAGE) Neueste Nachrichten

pulisher
08:49 AM

SAGE Acquisition Advances as Antitrust Waiting Period Ends - GuruFocus

08:49 AM
pulisher
08:48 AM

Supernus announces expiration of HSR waiting period for Sage Therapeutics - TipRanks

08:48 AM
pulisher
08:26 AM

Supernus Pharmaceuticals Announces Expiration of - GlobeNewswire

08:26 AM
pulisher
08:25 AM

Supernus Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Sage Therapeutics, Inc. Tender Offer - Benzinga

08:25 AM
pulisher
08:25 AM

Supernus-Sage $12B Merger Gets Key Regulatory Green Light as Tender Offer Deadline Nears - Stock Titan

08:25 AM
pulisher
08:04 AM

Is it the right time to buy Sage Therapeutics Inc. stockFree Wealth Planning Blueprint - jammulinksnews.com

08:04 AM
pulisher
06:22 AM

What institutional investors are buying Sage Therapeutics Inc. stockDiscover stocks with explosive growth potential - jammulinksnews.com

06:22 AM
pulisher
01:44 AM

What are analysts’ price targets for Sage Therapeutics Inc. in the next 12 monthsFree Stock Market Return Analysis - jammulinksnews.com

01:44 AM
pulisher
Jul 27, 2025

What catalysts could drive Sage Therapeutics Inc. stock higher in 2025Access daily stock market expert updates - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How strong is Sage Therapeutics Inc. company’s balance sheetGet expert analysis on top stock picks - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

When is Sage Therapeutics Inc. stock expected to show significant growthExplosive trading growth - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What makes Sage Therapeutics Inc. stock price move sharplyAchieve impressive returns with smart timing - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 26, 2025

BML Capital Management LLC Acquires Shares of 135,095 Sage Therapeutics, Inc. (NASDAQ:SAGE) - MarketBeat

Jul 26, 2025
pulisher
Jul 26, 2025

Sage Therapeutics (NASDAQ:SAGE) Sees Unusually-High Trading VolumeShould You Buy? - MarketBeat

Jul 26, 2025
pulisher
Jul 26, 2025

Sage Therapeutics (SAGE) Expected to Announce Earnings on Wednesday - MarketBeat

Jul 26, 2025
pulisher
Jul 25, 2025

Cwm LLC Increases Holdings in Sage Therapeutics, Inc. (NASDAQ:SAGE) - MarketBeat

Jul 25, 2025
pulisher
Jul 25, 2025

Is Sage Therapeutics Inc. a good long term investmentOutstanding stock performance - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 23, 2025

What drives Sage Therapeutics Inc. stock priceUnbelievable profit margins - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Sage Therapeutics Inc. stockFree Investment Community - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Sage Therapeutics Inc. Stock Analysis and ForecastMarket-beating returns - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Layoff Tracker: GSK, Sail, BioNTech Cut Staff for Second Time This Year - BioSpace

Jul 22, 2025
pulisher
Jul 20, 2025

Sage Therapeutics (NASDAQ:SAGE) Stock Price Crosses Above 50 Day Moving AverageHere's Why - MarketBeat

Jul 20, 2025
pulisher
Jul 18, 2025

ALERT: Rowley Law PLLC Is Investigating Proposed Acquisition of Sage Therapeutics, Inc. - 富途牛牛

Jul 18, 2025
pulisher
Jul 15, 2025

Status Epilepticus Pipeline 2025: Key Companies, MOA, ROA, - openPR.com

Jul 15, 2025
pulisher
Jul 15, 2025

Status Epilepticus Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Marinus Pharmac, Pfizer, UCB Biopharma, Rafa Laboratories, Sage Therapeutics - The Globe and Mail

Jul 15, 2025
pulisher
Jul 14, 2025

SAGE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sage Therapeutics, Inc.SAGE - Business Wire

Jul 14, 2025
pulisher
Jul 13, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sage Therapeutics, Inc. (SAGE) And Encourages Stockholders to Reach Out - ACCESS Newswire

Jul 13, 2025
$23.09
price down icon 1.32%
$37.06
price up icon 1.06%
$101.75
price down icon 2.12%
$27.45
price down icon 4.26%
$112.79
price down icon 2.19%
biotechnology ONC
$294.51
price up icon 1.04%
Kapitalisierung:     |  Volumen (24h):